Stately Bio
Palo Alto, United States · Founded 2022 · $12.0M raised
- Headquarters
- Palo Alto
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- statelybio.com
- Total Funding
- $12.0M
- Last Round
- $12.0M SeedMay 2025
- Rounds
- 1
About
Developing next-generation regenerative medicines with advanced ML cell imaging platform
Summary
Stately Bio is an Artificial Intelligence company based in Palo Alto, United States, founded in 2022. It has raised $12.0M in total across 1 round, most recently a $12.0M Seed round in May 2025. Investors include AIX Ventures, Dimension Capital and Foothill Ventures.
Funding History
May 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/stately-bio"><img src="https://indexed.vc/api/badge/company/stately-bio" alt="Stately Bio on Indexed.vc" width="260" height="76" /></a>